SHANGHAI, China, Aug. 29, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the United States Food and Drug Administration (the
TO: ALL PERSONS WHO OWN SHARES OF STATE STREET CORPORATION COMMON STOCK AS OF JUNE 24, 2021 (“SHAREHOLDERS”): BOSTON, Aug. 27, 2021 (GLOBE NEWSWIRE) — Please read this notice carefully and in its entirety. Your rights may be affected by
Nyxoah Appoints Rita Johnson-Mills to its Board of Directors Mont-Saint-Guibert, Belgium – August 27, 2021, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization
For the third consecutive year, the Gartner report recognizes Epicor for its vision and execution Austin, Texas, Aug. 27, 2021 (GLOBE NEWSWIRE) — Epicor Software Corporation, a global provider of industry-specific enterprise software to promote business growth, has been named
ImmunoBrain Checkpoint Awarded $5 Million US NIA Grant for Phase 1b Alzheimer’s Disease Proof-of-Mechanism Study of Anti-PD-L1 IBC-Ab002 NEW YORK, Friday August 27, 2021 – ImmunoBrain Checkpoint Inc. (“IBC”) an innovative biopharmaceutical company developing potential disease-modifying immune therapies that harness
SHANGHAI, China, Aug. 27, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the National Medical Products Administration (NMPA) of China
First closing of dedicated Canadian fund provides investing capacity of more than CAD$550 million for investments in senior living, student housing, medical office, life sciences, storage, and digital assets CHICAGO and TORONTO, Aug. 26, 2021 (GLOBE NEWSWIRE) — Harrison Street,
Acuant will provide KYC and Identity Verification tech for seamless, compliant financial solutions LOS ANGELES, Aug. 26, 2021 (GLOBE NEWSWIRE) — Acuant, the leading global Trusted Identity Platform for fraud prevention and AML compliance, today announced a new partnership with
